UMRX
Unum Therapeutics Inc. · NASDAQ
Unum Therapeutics Inc. (UMRX) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for UMRX in the last 30 days. The most recent was published Oct 5, 2020.
UMRX FAQ
6 questionsWhat is the latest news on UMRX?
Quantisnow has not tracked any new filings, ratings or press releases for UMRX in the last 30 days. The most recent wire item was published on October 5, 2020.Where does UMRX stock trade?
Unum Therapeutics Inc. (UMRX) is listed on NASDAQ.What sector and industry is UMRX in?
Unum Therapeutics Inc. operates in the Health Care sector, Major Pharmaceuticals industry.When did Unum Therapeutics Inc. go public?
Unum Therapeutics Inc. (UMRX) completed its IPO in 2018.What companies are similar to UMRX?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare UMRX side-by-side with any of them on Quantisnow.How can I track UMRX on Quantisnow?
Quantisnow aggregates Unum Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UMRX to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change